Cargando…

Immunization with Toxoplasma gondii peroxiredoxin 1 induces protective immunity against toxoplasmosis in mice

To develop a vaccine against Toxoplasma gondii, a vaccine antigen with immune-stimulating activity is required. In the present study, we investigated the immunogenicity and prophylactic potential of T. gondii peroxiredoxin 1 (TgPrx1). The TgPrx1 was detected in the ascitic fluid of mice 6 days posti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fereig, Ragab M., Kuroda, Yasuhiro, Terkawi, Mohamad Alaa, Mahmoud, Motamed Elsayed, Nishikawa, Yoshifumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407612/ https://www.ncbi.nlm.nih.gov/pubmed/28448521 http://dx.doi.org/10.1371/journal.pone.0176324

Ejemplares similares

Genetic Disruption of Toxoplasma gondii peroxiredoxin (TgPrx) 1 and 3 Reveals the Essential Role of TgPrx3 in Protecting Mice from Fatal Consequences of Toxoplasmosis
por: Fereig, Ragab M., et al.
Publicado: (2022)

Exposure to Toxoplasma gondii in Asian Elephants (Elephas maximus indicus) in Thailand
por: Udonsom, Ruenruetai, et al.
Publicado: (2021)

Transcriptomic Analysis of the Effects of Chemokine Receptor CXCR3 Deficiency on Immune Responses in the Mouse Brain during Toxoplasma gondii Infection
por: Umeda, Kousuke, et al.
Publicado: (2021)

Toxoplasma gondii Dense Granule Proteins 7, 14, and 15 Are Involved in Modification and Control of the Immune Response Mediated via NF-κB Pathway
por: Ihara, Fumiaki, et al.
Publicado: (2020)

Involvement of Toll-like receptor 2 in the cerebral immune response and behavioral changes caused by latent Toxoplasma infection in mice
por: Ihara, Fumiaki, et al.
Publicado: (2019)

Immune response against toxoplasmosis—some recent updates RH: Toxoplasma gondii immune response
por: Sana, Madiha, et al.
Publicado: (2022)

Induction of Protective Immunity against Toxoplasmosis in BALB/c Mice Vaccinated with Toxoplasma gondii Rhoptry-1
por: Sonaimuthu, Parthasarathy, et al.
Publicado: (2016)

Toxoplasma gondii GRA15 DNA Vaccine with a Liposomal Nanocarrier Composed of an SS-Cleavable and pH-Activated Lipid-like Material Induces Protective Immunity against Toxoplasmosis in Mice
por: Hasan, Tanjila, et al.
Publicado: (2021)

Evaluation of toxoplasmosis in pregnant women using dot-immunogold-silver staining with recombinant Toxoplasma gondii peroxiredoxin protein
por: Liu, Zhuan-zhuan, et al.
Publicado: (2020)

Diagnosis of toxoplasmosis and typing of Toxoplasma gondii
por: Liu, Quan, et al.
Publicado: (2015)

Partial Protective Effect of Intranasal Immunization with Recombinant Toxoplasma gondii Rhoptry Protein 17 against Toxoplasmosis in Mice
por: Wang, Hai-Long, et al.
Publicado: (2014)

Recombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c mice
por: Wang, Hai-Long, et al.
Publicado: (2016)

Intranasal immunization with recombinant Toxoplasma gondii actin depolymerizing factor confers protective efficacy against toxoplasmosis in mice
por: Liu, Zhuanzhuan, et al.
Publicado: (2016)

Immune Protection of Rhoptry Protein 21 (ROP21) of Toxoplasma gondii as a DNA Vaccine Against Toxoplasmosis
por: Zhang, Zhenchao, et al.
Publicado: (2018)

From Signaling Pathways to Distinct Immune Responses: Key Factors for Establishing or Combating Neospora caninum Infection in Different Susceptible Hosts
por: Fereig, Ragab M., et al.
Publicado: (2020)

Plasmodium berghei circumsporozoite protein encapsulated in oligomannose-coated liposomes confers protection against sporozoite infection in mice
por: Terkawi, Mohamad Alaa, et al.
Publicado: (2014)

Exploiting the Macrophage Production of IL-12 in Improvement of Vaccine Development against Toxoplasma gondii and Neospora caninum Infections
por: Fereig, Ragab M., et al.
Publicado: (2022)

Immunization With a Live-Attenuated RH:ΔNPT1 Strain of Toxoplasma gondii Induces Strong Protective Immunity Against Toxoplasmosis in Mice
por: Yang, Wen-Bin, et al.
Publicado: (2019)

Intranasal Immunisation with Recombinant Toxoplasma gondii Actin Partly Protects Mice against Toxoplasmosis
por: Yin, Li-Tian, et al.
Publicado: (2013)

Characterization of Toxoplasma gondii glyoxalase 1 and evaluation of inhibitory effects of curcumin on the enzyme and parasite cultures
por: Goo, Youn-Kyoung, et al.
Publicado: (2015)

Seroprevalence and risk factors analysis of Neospora caninum and Toxoplasma gondii in cattle of Beheira, Egypt
por: Metwally, Samy, et al.
Publicado: (2023)

A Novel Vaccine Candidate: Recombinant Toxoplasma gondii Perforin-Like Protein 2 Stimulates Partial Protective Immunity Against Toxoplasmosis
por: Tian, Xiaowei, et al.
Publicado: (2022)

Vaccination with Neospora GRA6 Interrupts the Vertical Transmission and Partially Protects Dams and Offspring against Neospora caninum Infection in Mice
por: Fereig, Ragab M., et al.
Publicado: (2021)

A novel Toxoplasma gondii TGGT1_316290 mRNA-LNP vaccine elicits protective immune response against toxoplasmosis in mice
por: Li, Dan, et al.
Publicado: (2023)

Advances in vaccine development and the immune response against toxoplasmosis in sheep and goats
por: Hasan, Tanjila, et al.
Publicado: (2022)

Toxoplasma gondii infection and toxoplasmosis in North Africa: a review
por: Rouatbi, Mariem, et al.
Publicado: (2019)

Immunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice
por: Liu, Yuan, et al.
Publicado: (2017)

DNA Vaccines Encoding Toxoplasma gondii Cathepsin C 1 Induce Protection against Toxoplasmosis in Mice
por: Han, Yali, et al.
Publicado: (2017)

Targeted Delivery of Toxoplasma gondii Antigens to Dendritic Cells Promote Immunogenicity and Protective Efficiency against Toxoplasmosis
por: Lakhrif, Zineb, et al.
Publicado: (2018)

Human immunity to Toxoplasma gondii
por: Fisch, Daniel, et al.
Publicado: (2019)

Toxoplasma gondii cathepsin proteases are undeveloped prominent vaccine antigens against toxoplasmosis
por: Zhao, Guanghui, et al.
Publicado: (2013)

Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii elongation factor 1-alpha
por: Wang, Shuai, et al.
Publicado: (2015)

RHΔgra17Δnpt1 Strain of Toxoplasma gondii Elicits Protective Immunity Against Acute, Chronic and Congenital Toxoplasmosis in Mice
por: Liang, Qin-Li, et al.
Publicado: (2020)

A live attenuated RHΔompdcΔuprt mutant of Toxoplasma gondii induces strong protective immunity against toxoplasmosis in mice and cats
por: Shen, Yu, et al.
Publicado: (2023)

Assessment in vitro of immunity against Toxoplasma gondii
Publicado: (1975)

Protective Effect Against Toxoplasmosis in BALB/c Mice Vaccinated With Toxoplasma gondii Macrophage Migration Inhibitory Factor
por: Liu, Kang, et al.
Publicado: (2019)

Genetic Divergence of Toxoplasma gondii Strains Associated with Ocular Toxoplasmosis, Brazil
por: Khan, Asis, et al.
Publicado: (2006)

Toxoplasma gondii Recombinant Antigens in the Serodiagnosis of Toxoplasmosis in Domestic and Farm Animals
por: Ferra, Bartłomiej, et al.
Publicado: (2020)

A Lactate Fermentation Mutant of Toxoplasma Stimulates Protective Immunity Against Acute and Chronic Toxoplasmosis
por: Xia, Ningbo, et al.
Publicado: (2018)

Identification of Toxoplasma Gondii Tyrosine Hydroxylase (TH) Activity and Molecular Immunoprotection against Toxoplasmosis
por: Zhang, Zhenchao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ekjd68uc9ss5udesd3f1t13i2j